Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors

US Patent 9630921 · Granted Apr 25, 2017

Estimated economic value: $89,213,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehyd2017
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehyd2017
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehyd2017
Drug combinations comprising a DGAT inhibitor and a PPAR-agonist2017
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors2016
Piperidine/piperazine derivatives2016